4.5. Analysis.

Comparison 4: Platinum‐sensitive recurrent EOC: PARPi monotherapy compared with chemotherapy, Outcome 5: Quality of Life ‐ Trial Outcome Index score of Functional Assessmentof Cancer Therapy—Ovarian Cancer questionnaire

Comparison 4: Platinum‐sensitive recurrent EOC: PARPi monotherapy compared with chemotherapy, Outcome 5: Quality of Life ‐ Trial Outcome Index score of Functional Assessmentof Cancer Therapy—Ovarian Cancer questionnaire